| Ms Virginia Janet Orduno, NP | |
|
4206 Retama Cir, Victoria, TX 77901-2757 | |
| (361) 552-0399 | |
| Not Available |
| Full Name | Ms Virginia Janet Orduno |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Gerontology |
| Location | 4206 Retama Cir, Victoria, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205562089 | NPI | - | NPPES |
| UNKNOWN | Other | UNKNOWN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 1073985 (Texas) | Secondary |
| 363LG0600X | Nurse Practitioner - Gerontology | 1073985 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Virginia Janet Orduno, NP Po Box 1890, Gonzales, TX 78629-1390 Ph: (830) 339-2067 | Ms Virginia Janet Orduno, NP 4206 Retama Cir, Victoria, TX 77901-2757 Ph: (361) 552-0399 |
News Archive
The key to a better drug delivery method for cancer patients may be growing all across the Midwest, South Dakota State University research suggests.
UvA professors Cees Snoek and Marcel Worring are starting a new public-private research lab together with researchers from the Inception Institute of Artificial Intelligence Ltd. from the United Arab Emirates led by Professor Ling Shao.
Millendo Therapeutics, a University of Michigan startup company, announced an exclusive license agreement with AstraZeneca for the worldwide development and commercialization rights to test a new compound, MLE4901, for the treatment of polycystic ovary syndrome.
Less than two years ago, the world came crashing in on Bill and Cheryl Darnell, SIDS America founders, when they went to wake their infant son, Billy, for his morning feeding and found him dead. Billy, who had seemed perfectly healthy just a few hours earlier, had fallen victim to Sudden Infant Death Syndrome, the leading cause of death among infants between 1 and 12 months of age in America.
Scientists have taken a major step closer to being able to 3D bioprint functional organs, after researchers devised a method of rebuilding components of the human heart, according to a study published in the August 2nd edition of Science.
› Verified 8 days ago